Increased prevalence of osteosarcopenia observed among hip fracture patients, suggests research
A new study published in the Journal of Orthopaedic Surgery and Research showed that more than 80% of patients with hip fractures had osteosarcopenia, 83.6% had sarcopenia, and 97.95% had osteopenia/osteoporosis.
As the world's population ages, hip fractures are expected to affect 6.3 million people globally by 2050. It is well known that hip fractures require prompt surgery. The primary goal is early mobilization and recovery in order to lower mortality and avoid potentially deadly medical consequences. In addition to the substantial risk of pain and impairment for those who survive, the global death rate is around 10% at one month and 36% at one year. Yet, hip fractures cause 4.5 million disabilities annually and rank in the top 10 worldwide, despite intensive intervention and rehabilitation.
Sarcopenia is characterized by a decrease in the size and quantity of muscle fibers, which may be brought on by changes in the central and peripheral neurological systems, hormones, immunological factors, and lifestyle choices. A rising geriatric monster, osteosarcopenia increases the risk of falls, fractures, disability, and death. Determining the frequency and risk factors of osteosarcopenia in individuals with hip fractures was the aim of this cross-sectional investigation.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.